JPMorgan Chase & Co. Trims Position in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

featured-image

JPMorgan Chase & Co. decreased its position in Establishment Labs Holdings Inc. (NASDAQ:ESTA – Free Report) by 38.7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 554,061 shares of the company’s stock after selling 349,354 shares during the quarter. JPMorgan Chase & Co. owned [...]

JPMorgan Chase & Co. decreased its position in Establishment Labs Holdings Inc. ( NASDAQ:ESTA – Free Report ) by 38.

7% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 554,061 shares of the company’s stock after selling 349,354 shares during the quarter. JPMorgan Chase & Co.



owned approximately 1.98% of Establishment Labs worth $25,526,000 at the end of the most recent quarter. Several other institutional investors and hedge funds have also bought and sold shares of ESTA.

R Squared Ltd bought a new position in shares of Establishment Labs in the 4th quarter worth approximately $36,000. KLP Kapitalforvaltning AS purchased a new stake in Establishment Labs during the fourth quarter valued at approximately $161,000. Handelsbanken Fonder AB raised its position in Establishment Labs by 32.

3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock worth $378,000 after acquiring an additional 2,000 shares during the period. Verition Fund Management LLC boosted its stake in shares of Establishment Labs by 22.

8% during the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company’s stock worth $407,000 after acquiring an additional 1,746 shares during the last quarter. Finally, HighTower Advisors LLC boosted its stake in shares of Establishment Labs by 32.

5% during the 3rd quarter. HighTower Advisors LLC now owns 10,311 shares of the company’s stock worth $446,000 after acquiring an additional 2,529 shares during the last quarter. 72.

91% of the stock is owned by hedge funds and other institutional investors. Analyst Ratings Changes Separately, Stephens restated an “overweight” rating and issued a $52.00 price objective on shares of Establishment Labs in a research note on Thursday, March 6th.

One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $57.

40. Establishment Labs Stock Performance ESTA opened at $27.31 on Wednesday.

The company has a 50 day simple moving average of $36.38 and a two-hundred day simple moving average of $40.32.

The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.

29. The firm has a market cap of $787.78 million, a P/E ratio of -10.

59 and a beta of 0.77. Establishment Labs Holdings Inc.

has a 1-year low of $26.96 and a 1-year high of $60.12.

Establishment Labs ( NASDAQ:ESTA – Get Free Report ) last issued its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.

64) by ($0.34). The firm had revenue of $44.

51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative return on equity of 184.

55% and a negative net margin of 46.13%. Equities analysts forecast that Establishment Labs Holdings Inc.

will post -2.41 earnings per share for the current fiscal year. Establishment Labs Profile ( Free Report ) Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery.

The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. Featured Stories Five stocks we like better than Establishment Labs Utilities Stocks Explained – How and Why to Invest in Utilities Tariff-Proof Stocks: 3 Big Bargains With Huge Upside Potential Roth IRA Calculator: Calculate Your Potential Returns Qualcomm Breaks Down But RSI Signals It’s Severely Oversold 3 Grocery Stocks That Are Proving They Are Still Essential Tesla’s #1 Bull Cuts Target But Says It’s Still a Buy Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.

com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. ( NASDAQ:ESTA – Free Report ). Receive News & Ratings for Establishment Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Establishment Labs and related companies with MarketBeat.

com's FREE daily email newsletter ..